FR2398051A1 - Nouveau fragment du glucagon et ses derives - Google Patents

Nouveau fragment du glucagon et ses derives

Info

Publication number
FR2398051A1
FR2398051A1 FR7821686A FR7821686A FR2398051A1 FR 2398051 A1 FR2398051 A1 FR 2398051A1 FR 7821686 A FR7821686 A FR 7821686A FR 7821686 A FR7821686 A FR 7821686A FR 2398051 A1 FR2398051 A1 FR 2398051A1
Authority
FR
France
Prior art keywords
glucagon
new
derivatives
new fragment
gln
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7821686A
Other languages
English (en)
French (fr)
Other versions
FR2398051B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP8855677A external-priority patent/JPS5424868A/ja
Priority claimed from JP11424277A external-priority patent/JPS5446776A/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of FR2398051A1 publication Critical patent/FR2398051A1/fr
Application granted granted Critical
Publication of FR2398051B1 publication Critical patent/FR2398051B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/605Glucagons

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7821686A 1977-07-22 1978-07-21 Nouveau fragment du glucagon et ses derives Granted FR2398051A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8855677A JPS5424868A (en) 1977-07-22 1977-07-22 Novel glucagon fragment
JP11424277A JPS5446776A (en) 1977-09-21 1977-09-21 Novel peptide

Publications (2)

Publication Number Publication Date
FR2398051A1 true FR2398051A1 (fr) 1979-02-16
FR2398051B1 FR2398051B1 (enExample) 1983-09-16

Family

ID=26429925

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7821686A Granted FR2398051A1 (fr) 1977-07-22 1978-07-21 Nouveau fragment du glucagon et ses derives

Country Status (4)

Country Link
US (1) US4206199A (enExample)
DE (2) DE2832090A1 (enExample)
FR (1) FR2398051A1 (enExample)
GB (1) GB2002387B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2467841A1 (fr) * 1979-10-16 1981-04-30 Toyo Jozo Kk Fragment de glucagon et son application a la preparation d'un anticorps specifique
FR2602679A1 (fr) * 1986-08-14 1988-02-19 Inst Nat Sante Rech Med Nouvelles compositions pharmaceutiques renfermant comme principe actif regulateur du mouvement des ions calcium un fragment du glucagon, et preparation d'un tel fragment

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5539702A (en) * 1978-08-30 1980-03-19 Takeda Chem Ind Ltd Method of measuring enzyme immunity of pancreas glucagon
JPS56163456A (en) * 1980-05-21 1981-12-16 Otsuka Pharmaceut Co Ltd Preparation of antigen
US4423034A (en) * 1980-10-16 1983-12-27 Toyo Jozo Kabushiki Kaisha Process for the preparation of antibodies
US5693741A (en) 1988-03-15 1997-12-02 The Boeing Company Liquid molding compounds
US4430326A (en) 1981-12-22 1984-02-07 University Patents, Inc. Method of diminishing glucose levels resulting from endogenous glucagon
GB2160312B (en) * 1984-04-13 1987-09-16 South African Inventions Adjuvant for immunisation
US5089390A (en) * 1987-09-04 1992-02-18 Syntex (U.S.A.) Inc. 2-methyl-4-hexene- and 2-methyl-4-heptene-1,2-diol derivatives
US6887470B1 (en) 1999-09-10 2005-05-03 Conjuchem, Inc. Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
US20040266673A1 (en) * 2002-07-31 2004-12-30 Peter Bakis Long lasting natriuretic peptide derivatives
US7601691B2 (en) * 1999-05-17 2009-10-13 Conjuchem Biotechnologies Inc. Anti-obesity agents
BR0010750A (pt) * 1999-05-17 2002-02-26 Conjuchem Inc Peptìdeos insulinotrópicos de longa duração
EP1582223A4 (en) * 2003-01-10 2007-01-17 Niigata Tlo Corp VECTOR FOR GENE THERAPY AND METHOD FOR THE QUANTIFICATION OF A TARGET PROTEIN IN MAMMALIAN OR CULTURAL CELLS BY APPLYING THE VECTOR FOR GENE THERAPY
HRP20060362A2 (en) * 2004-04-23 2007-03-31 Conjuchem Biotechnologies Inc. Method for the purification of albumin conjugates
US8039432B2 (en) * 2005-11-09 2011-10-18 Conjuchem, Llc Method of treatment of diabetes and/or obesity with reduced nausea side effect
CN101384623B (zh) * 2005-12-22 2013-07-24 常山凯捷健生物药物研发(河北)有限公司 白蛋白与治疗剂的预成型偶联物的制备方法
US20090099074A1 (en) * 2007-01-10 2009-04-16 Conjuchem Biotechnologies Inc. Modulating food intake
CN107001461A (zh) 2014-09-16 2017-08-01 瑞泽恩制药公司 抗胰高血糖素抗体及其使用方法
NZ750953A (en) 2016-08-30 2026-02-27 Regeneron Pharma Methods of treating severe insulin resistance by interfering with glucagon receptor signaling
US20190248888A1 (en) 2016-10-20 2019-08-15 Regeneron Pharmaceuticals, Inc. Methods of lowering blood glucose levels
CA3071387A1 (en) 2017-08-22 2019-02-28 Regeneron Pharmaceuticals, Inc. Methods of treating urea cycle disorders by interfering with glucagon receptor signaling

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1232040A (enExample) * 1967-08-19 1971-05-19
US3979506A (en) * 1974-10-11 1976-09-07 Pierce Chemical Company Radioactive compounds for labeling proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1643345C3 (de) * 1967-08-19 1975-09-25 Hoechst Ag, 6000 Frankfurt Glucagonderivat und Verfahren zur Herstellung von Glucagon

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1232040A (enExample) * 1967-08-19 1971-05-19
US3979506A (en) * 1974-10-11 1976-09-07 Pierce Chemical Company Radioactive compounds for labeling proteins

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
EXBK/67 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2467841A1 (fr) * 1979-10-16 1981-04-30 Toyo Jozo Kk Fragment de glucagon et son application a la preparation d'un anticorps specifique
FR2602679A1 (fr) * 1986-08-14 1988-02-19 Inst Nat Sante Rech Med Nouvelles compositions pharmaceutiques renfermant comme principe actif regulateur du mouvement des ions calcium un fragment du glucagon, et preparation d'un tel fragment
WO1988001174A1 (fr) * 1986-08-14 1988-02-25 Institut National De La Sante Et De La Recherche M Un fragment de glucagon regulateur du mouvement des ions calcium

Also Published As

Publication number Publication date
DE2832090C2 (enExample) 1989-07-20
DE2858718C2 (enExample) 1989-07-06
GB2002387A (en) 1979-02-21
DE2832090A1 (de) 1979-02-08
US4206199A (en) 1980-06-03
GB2002387B (en) 1982-02-10
FR2398051B1 (enExample) 1983-09-16

Similar Documents

Publication Publication Date Title
FR2398051A1 (fr) Nouveau fragment du glucagon et ses derives
GB1527562A (en) Substituted-methyl-11-cyano-9,10-dihydroethanoanthracene-11-carboxylates useful as intermediates
FR2364198A1 (fr) Nouveaux produits a action herbicide, derives d'acides phenoxyvaleriques
FR2384751A1 (fr) Nouveaux derives de la taurine a activite neuro-musculaire renforcee
BG29132A3 (en) Method of obtaining of cyclohexan derivatives
FR2275210A1 (fr) Nouveaux derives de benzimidazolinone
FR2358406A1 (fr) Derives d'acides 5-aroyl-1,2-dihydro-3h-pyrrolo (1,2-a)pyrrole-1-carboxyliques, leur obtention et leur application a titre de medicament
GB1398993A (en) Triazolyl-styryl compounds
GB1268951A (en) Phenoxy-amines
GB1514657A (en) Substituted acetic acid esters processes for producing them and compositions containing them
FR2378802A1 (fr) Nouveaux polystyrenes modifies et leur application a la catalyse de la transformation d'isocyanates en carbodiimides
BG48333A3 (en) Method for preparing of 2, 2- dimethyl cyclopropane carbonic acid derivatives
FR2376846A1 (fr) Nouveaux derives de la piperidine
SE7702130L (sv) Forfarande for framstellning av n-(merkaptoacyl)-histidiner
FR2430943A1 (fr) Nouveaux derives disulfures
FR2378518A1 (fr) Nouveaux medicaments a base de derives de tetrahydrodibenzopyranne
FR2363541A1 (fr) Acyloxy-n,n' diacylmalonamides et leur mode de preparation
FR2399440A1 (fr) 1-(5-fluoro-uracilyl-1)-2,5-di-o-acetyl-b-d-glucofuranurono-6,3-lactone et son application en therapeutique
GB1291687A (en) A method for the production of formylnitrile derivatives
FR2372784A1 (fr) Derives aldehydiques de cyclopentane utiles comme agents odoriferants
FR2381038A2 (fr) Nouveaux derives de la carbamoyloxymethyl-5 oxazolidinone-2 leur procede de preparation et leur application en therapeutique
ES429517A1 (es) Procedimiento para la obtencion de agentes herbicidas.
FR2434149A1 (fr) Nouveaux derives de la l-cysteine
FR2360589A1 (fr) Procede sur la production de derives de 5-fluorouracile en presence d'un catalyseur
FR2377406A1 (fr) Composes de tetrathiapentalene et de tetraselenapentalene

Legal Events

Date Code Title Description
ST Notification of lapse